You are here

Make Coarser Make Bigger capsules

Make Coarser Make Bigger capsules pose a serious risk to your health and should not be taken.

18 March 2019

The Therapeutic Goods Administration (TGA) has tested a product labelled Make Coarser Make Bigger capsules and found that:

  • The capsules contain the undeclared substances 2-mercaptobenzothiazole, diclofenac and glibenclamide.

Consumers are advised that in Australia, glibenclamide is a prescription-only substance and oral diclofenac is a pharmacy only substance. 2-Mercaptobenzothiazole has no known therapeutic use.

The supply of Make Coarser Make Bigger capsules containing undisclosed 2-mercaptobenzothiazole, diclofenac and glibenclamide is illegal.

Make Coarser Make Bigger capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.

Information for consumers

  • Stop taking Make Coarser Make Bigger capsules and take any remaining capsules to your local pharmacy for safe disposal.
  • If you have any concerns arising from your use of this product, consult your health care practitioner.

Action the TGA is taking

The TGA is working with the Australian Border Force (ABF) to help stop future shipments Make Coarser Make Bigger capsules from entering Australia.

If these capsules are found at the border by the ABF they will be seized and destroyed.

The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites and has produced a short video on the risks associated with buying medicines and medical devices online. Products purchased over the Internet:

  • may contain undisclosed and potentially harmful ingredients
  • may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.

Report counterfeit medicines and medical devices

If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA:

Contact details
Phone 1800 020 653
Online: Report a perceived breach of the Therapeutic Goods Act or questionable practices relating to therapeutic products